The Vermont Legislature has given final approval to a wide-ranging agriculture bill that includes changes to hemp oversight, farm regulations, food processing rules and agricultural tax policy, sending the measure to Governor Phil Scott. Senate Bill 323 was passed by the Senate and House after the Senate concurred with changes made by the House. The …
Minnesota Governor Signs Omnibus Marijuana Bill Into Law
Minnesota Governor Tim Walz has signed into law a sweeping omnibus marijuana bill that makes wide-ranging changes to the state’s legal marijuana system, including new licensing rules, expanded medical marijuana protections, new hemp product provisions and greater regulatory authority for the Office of Cannabis Management. Senate File 4401, sponsored by State Senator David Dibble (D), …
California Marijuana Sales Generate Nearly $248 Million in Tax Revenue in First Quarter of 2026
California marijuana retailers generated nearly $248 million in tax revenue for the state during the first quarter of 2026, bringing the state’s total marijuana tax haul to more than $8.1 billion since adult-use sales began in 2018. The California Department of Tax and Fee Administration reported that, as of May 18, the state had collected …
Vermont House Approves Bill to Double Marijuana and Hashish Possession and Purchase Limits, Allow Marijuana Events
The Vermont House of Representatives just voted in favor of a bill that would double the state’s legal marijuana possession and purchase limits while creating a limited marijuana event program. Senate Bill 278, which previously passed the full Senate, was approved by the House with amendments, meaning it must return to the Senate for a …
Missouri Regulators Issue Recall for Marijuana Vape Products Over Testing Issue
Missouri marijuana regulators have issued a recall for products manufactured by CPC of Missouri – Smithville, LLC, after determining that certain vape products were not tested in accordance with state requirements. The Missouri Division of Cannabis Regulation announced the recall today in partnership with the company, which operates under manufacturing license MAN000016. Regulators said the …
New York Cannabis Office Releases Listen and Learn Report on Community Cannabis Education Feedback
New York marijuana regulators have released a new report highlighting what young people, parents and other trusted adults say they need when it comes to marijuana education, with findings based on more than 450 participants across 23 listening sessions. The New York State Office of Cannabis Management announced the release of its Listen and Learn …
Study Finds CBD Improves Memory and Reduces Brain Oxidative Stress After Chronic Stress and Alcohol Exposure
A new study published in the Journal of Xenobiotics found that cannabidiol (CBD) improved memory-related performance and reduced brain oxidative stress in female rats exposed to chronic stress and alcohol. Researchers from George Emil Palade University of Medicine studied 16 female Wistar rats, half of which received CBD at a dose of 10 mg/kg. The …
Pennsylvania Medical Marijuana Sales Top $453 Million in Q1, Up 6% From 2025
Pennsylvania’s medical cannabis dispensaries sold $453.3 million worth of products during the first quarter of 2026, marking a 6% increase from the same period last year. According to newly released aggregate transaction data, dispensaries sold $453,302,829 worth of medical marijuana products from January through March. That’s up from $427,548,280 in the first quarter of 2025, …
Bloom Cannabis Says Ohio Hemp-Derived THC Ban Shows Importance of Licensed Dispensaries
Bloom Cannabis says Ohio’s ban on hemp-derived THC products is underscoring the importance of buying marijuana products through licensed dispensaries that operate under state testing, labeling and tracking rules. The Ohio dispensary operator, which has locations in Columbus, Akron, Painesville Township and Seven Mile, said the new restrictions have left many consumers looking for clearer …
Clinical Trial Finds Full-Spectrum CBD Well Tolerated in Adults With HIV
A randomized clinical trial found that low-dose full-spectrum cannabidiol (CBD) was well tolerated over 12 weeks among adults with long-term, virally suppressed HIV, with no meaningful negative impact on liver function, kidney function or key HIV-related measures. The study, published in Cannabis & Cannabinoid Research, was conducted by researchers affiliated with Centre Hospitalier Universitaire d’Orléans, …













